Novo Nordisk Looks to Target Hair Loss in Consumer Push
The maker of Ozempic and Wegovy seeks to expand its direct-to-consumer pharmaceutical business as rival Eli Lilly outpaces in weight-loss drugs.
Beauty
Analysis and advice on the fast-evolving beauty business.
Lilly’s GLP-1 Windfall to Fund Investments in Women’s Health
The pharmaceutical giant has been assembling experts and hunting for new medicines across conditions including bone health and endometriosis, sources told Bloomberg.
How David Is Making Protein Sexy
Fresh off a $2.25 billion valuation for its parent company, the wellness startup has a new launch, campaign and mandate to conquer calorie-counting consumers.
Vegamour Acquired by Belle Brands
The premium hair care line, known for its anti-hair-loss serums and supplements, has been acquired by the private equity-backed platform.
Dior Pushes ‘Haute Wellness’ Strategy
The label’s powerful beauty division is upgrading its spa offering and hiring Pilates instructors and sleep experts as it goes head-to-head with hotels and retreats in a bid to tap the buoyant high-end wellness market.
What Happens When Weight-Loss Drugs Don’t Work?
Up to a third of participants in GLP-1 clinical trials lose less than 5 percent of their body weight, stumping researchers and disillusioning some consumers.
How Body Care Became Beauty’s Most Covetable Category
With a raft of high-profile acquisitions, sponsors and strategics are looking at the segment with fresh interest. That’s making it harder to stand out, but smart brands are focussing on ownable niches.
The Back-to-School Beauty Rush
As tweens pack skin barrier creams alongside their pencil cases, retail giants are turning late summer into a major revenue driver for the personal care category.
Kiko Milano’s American Dream
This week, Priya Rao has makeup on her mind, with the Italian beauty brand’s new Manhattan store, and recent launches from Fara Homidi and Gucci Westman.
What Makes Hair Shoppers Trade Up?
Increasingly sophisticated, premium dry shampoos are becoming key acquisition tools — if brands can pry customers away from their drugstore favourites.
Who’s Winning and Losing in Beauty’s First Half
BoF Senior Beauty Correspondent Daniela Morosini joins Sheena Butler-Young on The Debrief to break down what 2026 earnings so far reveal about the state of beauty — where growth is concentrated, where the cracks are showing, and what to watch in the second half.
What Sephora’s TikTok Shop Launch Means for Beauty
The debut of the retailer’s new TikTok Shop storefront, which offers limited-edition exclusive products released each month, changes the rules of beauty retail.
Wella Company’s IPO Plan: Wipe Out Debt, Win New Customers
After swinging back to profit, the American hair and nail care company has filed to go public, with plans to deleverage its business and take on the competition.
THE NEWS IN BRIEF
PR Agency CGC Launches Performance Media Division
Known for its premium beauty clients including Glossier and Hermès Beauty, the agency’s new division combines influencer marketing and AI insights.
Luxury Perfume Line Roja London Acquired by Extravaganza Beauty
Master perfumer and founder Roja Dove will remain with the brand in a new consultancy role.
Olaplex Names New CEO
Christoph Kaul will succeed Amanda Baldwin, who led the hair care label through its acquisition by Henkel earlier this year.
Perelel Expands C-Suite, Tapping Rare Beauty’s CMO
Known for its prenatal vitamins, the wellness label has hired Rare Beauty's Ashley Murphy as its chief marketing officer, while Anjelika Temple moves into the chief creative officer role.
Supergoop Announces Chief Commercial Officer
The sunscreen label has appointed former Coty executive Jamie Parker to the newly created role as it gears up to become a “global skin health company.”
L’Oréal Steals French Stock Market Crown From LVMH
The cosmetics group became France’s most valuable listed company on Tuesday, the first time since 2017 that a non-luxury company has claimed the top spot at the end of a trading day.
Kimberly-Clark Prepares Asset Sales to Win EU Nod for Kenvue Deal
The US consumer goods giant is preparing concessions to address EU antitrust concerns about its bid for Tylenol maker Kenvue that could help it win approval for the $40 billion deal, sources told Reuters.